Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Non-Current Assets: 2021-2024

Historic Non-Current Assets for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $85.6 million.

  • Prime Medicine's Non-Current Assets rose 77.14% to $153.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.6 million, marking a year-over-year increase of 77.14%. This contributed to the annual value of $85.6 million for FY2024, which is 68.30% up from last year.
  • Prime Medicine's Non-Current Assets amounted to $85.6 million in FY2024, which was up 68.30% from $50.9 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Non-Current Assets registered a high of $85.6 million during FY2024, and its lowest value of $31.3 million during FY2021.
  • For the 3-year period, Prime Medicine's Non-Current Assets averaged around $66.7 million, with its median value being $63.7 million (2022).
  • As far as peak fluctuations go, Prime Medicine's Non-Current Assets spiked by 103.65% in 2022, and later declined by 20.13% in 2023.
  • Yearly analysis of 4 years shows Prime Medicine's Non-Current Assets stood at $31.3 million in 2021, then spiked by 103.65% to $63.7 million in 2022, then dropped by 20.13% to $50.9 million in 2023, then spiked by 68.30% to $85.6 million in 2024.